» Articles » PMID: 26383211

Gastrointestinal Stromal Tumor: May Mimic Adnexal Mass

Overview
Date 2015 Sep 19
PMID 26383211
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Gastrointestinal stromal tumors (GISTs) are rare tumor of the gastrointestinal tract. GISTs occur in the entire gastrointestinal tract and may also arise from the retroperitoneum, omentum and mesenteries. They are originated from gastrointestinal pacemaker cells (Cajal's interstitial cells) and range from benign tumors to sarcomas at all sites of occurrence. Diagnosis of GIST could be deceptive because of their similarity in appearance to gynecological neoplasms. We would like to present a case of a woman with GIST in the small intestine giving a imprint of an adnexal mass was diagnosed correctly during surgery. The diagnosis and treatment of GIST has been reformed over the past years. It is crucial to separate GISTs from possible misdiagnosis because their prognosis and treatment could be unlike clearly. The purpose of this case is to evaluate this rarely seen clinical entity, and thus, make some contribution to the literature.

Citing Articles

Gastrointestinal stromal tumors mimicking as gynecological tumors-A case series.

Trivedi K, Toppo S, Sharma A, Jha R, Bharati B, Pushpanjali J Family Med Prim Care. 2025; 13(12):5908-5911.

PMID: 39790741 PMC: 11709065. DOI: 10.4103/jfmpc.jfmpc_511_24.


Gastrointestinal Stromal Tumors (GISTs) Mimicking Primary Ovarian Tumors or Metastasizing to the Ovaries: A Systematic Literature Review.

Tonni G, Palicelli A, Bassi M, Torricelli F, Vacca I, Aguzzoli L Cancers (Basel). 2024; 16(13).

PMID: 39001368 PMC: 11240519. DOI: 10.3390/cancers16132305.

References
1.
Heinrich M, Corless C . Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy. J Surg Oncol. 2005; 90(3):195-207. DOI: 10.1002/jso.20230. View

2.
Singer S, Rubin B, Lux M, Chen C, Demetri G, Fletcher C . Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol. 2002; 20(18):3898-905. DOI: 10.1200/JCO.2002.03.095. View

3.
Miettinen M, El-Rifai W, H L Sobin L, Lasota J . Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol. 2002; 33(5):478-83. DOI: 10.1053/hupa.2002.124123. View

4.
Pierie J, Choudry U, Muzikansky A, Yeap B, Souba W, Ott M . The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg. 2001; 136(4):383-9. DOI: 10.1001/archsurg.136.4.383. View

5.
Sarlomo-Rikala M, Kovatich A, Barusevicius A, Miettinen M . CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 1998; 11(8):728-34. View